Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ligand Inter-Relation Analysis Via Graph Theory Predicts Macrophage Response.
Kang N, Hwang J, Jeong D, Choi JH, Thangam R, Min S, Hong H, Kim D, Rha H, Lee S, Jung H, Kim T, Zare I, Jung HJ, Najafabadi AH, Jung HD, Zhang K, Zhao P, Bian L, Kim HK, Kim JS, Song G, Yoon J, Park SG, Jang WY, Kang H. Kang N, et al. Among authors: yoon j. Adv Mater. 2024 Dec 24:e2414356. doi: 10.1002/adma.202414356. Online ahead of print. Adv Mater. 2024. PMID: 39719659
Photonic control of ligand nanospacing in self-assembly regulates stem cell fate.
Lee S, Yoo J, Bae G, Thangam R, Heo J, Park JY, Choi H, Kim C, An J, Kim J, Mun KR, Shin S, Zhang K, Zhao P, Kim Y, Kang N, Han SB, Kim D, Yoon J, Kang M, Kim J, Yang L, Karamikamkar S, Kim J, Zhu Y, Najafabadi AH, Song G, Kim DH, Lee KB, Oh SJ, Jung HD, Song HC, Jang WY, Bian L, Chu Z, Yoon J, Kim JS, Zhang YS, Kim Y, Jang HS, Kim S, Kang H. Lee S, et al. Among authors: yoon j. Bioact Mater. 2023 Dec 26;34:164-180. doi: 10.1016/j.bioactmat.2023.12.011. eCollection 2024 Apr. Bioact Mater. 2023. PMID: 38343773 Free PMC article.
Simultaneous Epigenetic and Gene Expression Profiling at Single Cell Resolution Uncovers Stem-Like Treg Subsets Induced With Oligonucleotide Expansion in Humans.
Nam HJ, Gong JR, Kim YH, Nguyen-Phuong T, Byun N, Yoon JH, Kim YC, Chung H, Lee BH, Kwon H, Lee W, Kang SJ, Park K, Cha B, Kim JI, Kim HJ. Nam HJ, et al. Among authors: yoon jh. Immune Netw. 2024 Oct 24;24(6):e39. doi: 10.4110/in.2024.24.e39. eCollection 2024 Dec. Immune Netw. 2024. PMID: 39801740 Free PMC article.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Among authors: yoon jh. Lancet. 2025 Jan 8:S0140-6736(24)02551-0. doi: 10.1016/S0140-6736(24)02551-0. Online ahead of print. Lancet. 2025. PMID: 39798579
12,471 results
You have reached the last available page of results. Please see the User Guide for more information.